CEO to depart 1,000-physician medical group

The CEO of Duly Health and Care, a medical group with more than 1,000 physicians, is exiting and a new leader has been appointed. 

Advertisement

Downers Grove, Ill.-based Duly Health and Care announced Sept. 7 that Steve Nelson is leaving his position as CEO and co-chair. “This was a planned departure and thoughtful transition that Steve will support,” a Duly spokesperson told The Chicago Tribune

Duly Health and Care, formerly DuPage Medical Group, appointed Tami Reller as its CEO and co-chair, effective Sept. 16. 

Ms. Reller, who has more than 20 years of leadership experience, was appointed CEO after serving as Duly Health and Care’s president since May 2021. She previously served as chief marketing, digital and experience officer at UnitedHealthcare. 

“Tami’s tenure in health­care along with her proven track record in expand­ing access to patient care, enhanc­ing the expe­ri­ence, and part­ner­ing with physi­cians to advance the orga­ni­za­tion, is immea­sur­able,” said Paul Merrick, MD, the chief physician executive and co-chair of Duly Health and Care. “Her appoint­ment is well-deserved. I look for­ward to part­ner­ing with Tami and our teams to meet peo­ple where they are and sup­port every step of their health and care jour­ney for health­i­er, hap­pi­er lives.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Integration & Physician Issues

Advertisement

Comments are closed.